MedPath

Study to Determine the Anti-plaque Efficacy of Commerical Toothpastes and an Oral Rinse

Phase 3
Completed
Conditions
Dental Plaque
Interventions
Drug: Fluoride
Drug: Triclosan, fluoride
Registration Number
NCT01024738
Lead Sponsor
Colgate Palmolive
Brief Summary

Calibration study to determine the anit-plaque efficacy of commerical toothpastes and an oral rinse

Detailed Description

Training of new examiners and validation of new clinical site to run 4 day short-term plaque studies. All products are commercially available.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
22
Inclusion Criteria
  • Be aged 18 to 65 years inclusive
  • Have a minimum of 15 natural uncrowned teeth (excluding 3rd molars) present
  • Give written informed consent
  • Be in good general health
  • No known history of allergy to personal care/consumer products or their ingredients, relevant to any ingredients in the test products as determined by the dental/medical professional monitoring the study
  • If of childbearing potential and on birth control (Diaphragm, Birth Control Pills, Birth Control Implants, IUD (Intrauterine device), condoms)
Exclusion Criteria
  • Medical condition which requires pre-medication (antibiotics) prior to dental
  • Visits/procedures
  • Allergy to chlorhexidine
  • Advanced periodontal disease (gum disease)
  • 5 or more decayed, untreated dental sites (cavities)
  • Diseases of the soft or hard oral tissues (gums or palate)
  • Orthodontic appliances that interfere with plaque rating
  • Abnormal salivary function
  • Use of drugs that can affect currently salivary flow or production
  • Use of antibiotics one (1) month prior to or during this study
  • Use of any over the counter medications other than analgesics (i.e. aspirin, ibuprofen, acetaminophen,naproxyn)
  • Pregnant or breastfeeding.
  • Participation in another research study in the month preceding this study
  • Allergic to common toothpaste or mouth rinse ingredients.
  • Immune compromised individuals (HIV, AIDS, immuno suppressive drug therapy) or individuals who have a high risk of infection from other causes

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Fluoride toothpasteFluoridenegative control toothpaste
Triclosan/Fluoride toothpasteTriclosan, fluoridepositive control toothpaste (Total toothpaste)
Chlorhexidine Oral RinseChlorhexidine Gluconatepositive control oral rinse
Primary Outcome Measures
NameTimeMethod
Plaque Index4 Days

Plaque score is Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

TKL Research, Inc.

🇺🇸

Paramus, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath